TRIM56 and metabolic dysfunction-associated steatotic liver disease: To investigate the effect of TRIM56 in hepatocytes on NAFLD pathogenesis in vivo, we generated hepatocyte-specific Trim56-KO mice by AAV8-Trim56-sgRNA-TBG-Cre injection.